title: Pulmonary nocardiosis in a non-Hodgkin's lymphoma patient.
abstract: Nocardiosis is an opportunistic infection especially in immunocompromised patients. Lungs are the most common infection sites and therapy poses some difficulties. We describe a case of pulmonary infection with Nocardia asteroides in a non-Hodgkin's lymphoma patient. Although the mortality from pulmonary nocardiosis is high in immunocompromised patients, our patient was successfully treated with trimethoprim-sulfamethoxazole (TMP/SMZ) and amikacin. Maintenance therapy with TMP/SMZ was continued for 1 year. This case supports the importance of the long-term maintenance treatment after the initial combination therapy.
authors.affiliation: Dept. of Clinical Bacteriology and Infectious Diseases, Ankara, Turkey. kenan@ttnet.net.tr
authors.forename: K
authors.initials: K
authors.lastname: Hizel
authors.forename: K
authors.initials: K
authors.lastname: Cağlar
authors.forename: H
authors.initials: H
authors.lastname: Cabadak
authors.forename: C
authors.initials: C
authors.lastname: Külah
mesh_terms: D000328:Adult; D000583:Amikacin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004334:Drug Administration Schedule; D006801:Humans; D016867:Immunocompromised Host; D008171:Lung Diseases / Q000188:drug therapy / Q000382:microbiology*; D008228:Lymphoma, Non-Hodgkin / Q000150:complications*; D008297:Male; D009617:Nocardia Infections / Q000188:drug therapy / Q000382:microbiology*; D009616:Nocardia asteroides / Q000302:isolation & purification / Q000472:pathogenicity; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D000583:Amikacin